Inclusive
7078
Renascience
4889
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
JP Stock MarketDetailed Quotes
3633 GMO Pepabo
- 1454
- +50+3.56%
20min DelayMarket Closed Jan 9 15:30 JST
7.95BMarket Cap-12.20P/E (Static)
1483High1404Low7.50KVolume1404Open1404Pre Close10.79MTurnover172052wk High0.40%Turnover Ratio5.47MShares111752wk Low111.58EPS TTM2.72BFloat Cap8750Historical HighLossP/E (Static)1.87MShs Float356Historical Low-119.16EPS LYR5.63%Amplitude--Dividend TTM3.65P/B100Lot Size--Div YieldTTM
GMO Pepabo Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.51%2.72B | -3.23%2.65B | 3.54%10.9B | -1.60%2.68B | -0.04%2.7B | 8.45%2.79B | 7.88%2.74B | -11.35%10.53B | -6.85%2.72B | -10.13%2.7B |
| Cost of revenue | 2.55%1.29B | 3.24%1.26B | 11.62%4.97B | 8.12%1.26B | 9.97%1.24B | 15.76%1.26B | 12.93%1.22B | -13.45%4.45B | -8.42%1.16B | -13.54%1.12B |
| Gross profit | -6.66%1.43B | -8.45%1.39B | -2.39%5.93B | -8.86%1.42B | -7.18%1.46B | 3.11%1.53B | 4.12%1.51B | -9.75%6.08B | -5.64%1.56B | -7.53%1.58B |
| Operating expense | -51.23%1.17B | -22.09%1.15B | 17.37%6.27B | -15.61%1.18B | -2.73%1.22B | 63.63%2.39B | 20.32%1.48B | -8.55%5.34B | -4.96%1.4B | -13.92%1.26B |
| Operating profit | 130.41%262.1M | 549.35%234.66M | -146.56%-340.99M | 49.41%241.77M | -24.54%243.1M | -3,940.30%-861.99M | -84.00%36.14M | -17.60%732.3M | -11.17%161.81M | 30.14%322.14M |
| Net non-operating interest income (expenses) | 67.11%-1.06M | 86.42%-1.92M | -921.54%-22.48M | -30.79%-2.2M | -428.86%-2.91M | -3,416.30%-3.24M | -11,785.12%-14.14M | -77.21%-2.2M | 28.19%-1.68M | -947.69%-551K |
| Non-operating interest income | 165.72%1.5M | 79.64%900K | -1.93%2.44M | 50.84%715K | -19.95%662K | 3.49%563K | -22.20%501K | 1.43%2.49M | -43.71%474K | 42.34%827K |
| Non-operating interest expense | -32.60%2.56M | 9.64%2.82M | 174.14%12.86M | 35.21%2.91M | 159.51%3.58M | 497.17%3.8M | 391.78%2.57M | 441.57%4.69M | 515.14%2.15M | --1.38M |
| Total other finance cost | ---- | ---- | --12.07M | --0 | --0 | --0 | --12.07M | ---- | ---- | ---- |
| Net investment income | 0 | 11.30%4.66M | 35.73%4.19M | 0 | 0 | 0 | 35.73%4.19M | -64.01%3.08M | 0 | 0 |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -135.16%-2.29M | -104.26%-3.12M | 6,866.06%46.19M | -468.52%-34.28M | -76.39%782K | 255.86%6.5M | 869.36%73.19M | -98.44%663K | -128.07%-6.03M | -74.41%3.31M |
| Income from associates and other participating interests | -774.86%-8.16M | 21.34%-5.29M | 203.49%4.26M | 526.42%14.77M | -141.87%-4.99M | 145.42%1.21M | -53.26%-6.73M | 129.25%1.4M | -126.27%-3.46M | 384.10%11.92M |
| Special income (charges) | -1,260.15%-118.92M | -118.92M | -89.43%10.25M | 0 | 0 | |||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 89.43%-10.25M | --0 | --0 |
| Less:Write off | ---- | ---- | --118.92M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non-operating income (expenses) | 14.98%6.88M | -44.21%6.72M | 23.89%32.11M | -23.58%8.12M | 29.09%5.97M | 18.44%5.98M | 114.31%12.04M | -11.31%25.92M | -26.24%10.63M | -31.54%4.62M |
| Income before tax | 130.24%257.47M | 125.16%235.7M | -151.29%-395.65M | -32.25%109.27M | -29.14%241.94M | -4,239.32%-851.54M | -57.81%104.69M | -27.58%771.42M | -29.55%161.27M | 27.16%341.44M |
| Income tax | 5.89%87.11M | 27.77%80.92M | -18.04%233.14M | -81.43%13.6M | -31.85%73.95M | 367.19%82.26M | -25.60%63.33M | -18.68%284.47M | 55.27%73.23M | 11.94%108.52M |
| Net income | 118.24%170.36M | 274.30%154.78M | -229.13%-628.79M | 8.66%95.66M | -27.88%168M | -31,594.06%-933.8M | -74.63%41.35M | -31.93%486.95M | -51.56%88.04M | 35.76%232.92M |
| Net income continuous operations | 118.24%170.36M | 274.29%154.78M | -229.13%-628.79M | 8.66%95.66M | -27.88%168M | -31,594.06%-933.8M | -74.63%41.35M | -31.93%486.95M | -51.56%88.04M | 35.76%232.92M |
| Noncontrolling interests | 0 | 0 | -23.14M | -3.43M | -2.81M | |||||
| Net income attributable to the company | 118.24%170.36M | 274.30%154.78M | -223.27%-628.79M | 4.58%95.66M | -28.74%168M | -7,512.28%-933.8M | -75.72%41.35M | -28.70%510.09M | -49.67%91.47M | 37.40%235.74M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 118.24%170.36M | 274.30%154.78M | -223.27%-628.79M | 4.58%95.66M | -28.74%168M | -7,512.28%-933.8M | -75.72%41.35M | -28.70%510.09M | -49.67%91.47M | 37.40%235.74M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 118.25%32.29 | 274.11%29.33 | -223.65%-119.16 | 4.38%18.12 | -28.55%31.84 | -7,473.33%-176.96 | -75.54%7.84 | -28.73%96.37 | -49.37%17.36 | 37.40%44.56 |
| Diluted earnings per share | 118.24%32.2841 | 274.11%29.33 | -223.65%-119.16 | 4.53%18.12 | -28.56%31.8353 | -7,512.49%-176.96 | -75.54%7.84 | -28.33%96.37 | -49.29%17.3341 | 38.13%44.56 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26.47%50 | -26.47%50 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |